Parasitic protozoa of the genus Leishmania have provided a useful perspective for
immunologists in terms of host defense mechanisms critical for the resolution of infection …

Leishmaniasis is a diverse group of clinical syndromes caused by protozoan parasites of the
genus Leishmania. The clinical manifestation of the disease varies from self-limiting …

In this study, we investigated in dogs the immunogenicity and protective immunity against
Leishmania (Leishmania) chagasi infection induced by vaccination with a formulation …

Leishmaniasis is caused by protozoan Leishmania parasites that are transmitted through
female sandfly bites. The disease is predominantly endemic to the tropics and semi-tropics …

Background A canine vaccine remains a promising approach for effective control of visceral
leishmaniasis (VL), given its complex epidemiology in areas where zoonotic VL is prevalent …

Background The present study aims to identify antigens in protein extracts of promastigote
and amastigote-like Leishmania (Leishmania) chagasi syn. L.(L.) infantum recognized by …

Currently, there is no licensed vaccine to protect against human visceral leishmaniasis (VL),
a potentially fatal disease caused by infection with Leishmania parasites. In the current …

Leishmaniasis is a major public health problem, and the alarming spread of parasite
resistance has increased the importance of discovering new therapeutic products. The …

Leishmaniasis is a major public health problem, and the alarming spread of parasite
resistance underlines the importance of discovering new therapeutic products. The present …

The study reported here aimed to develop an optimized nanoparticle delivery system for
amphotericin B (AmpB) using a polyelectrolyte complexation technique. For this, two …